ArticleJSES international2026
Exploratory anchor-derived six-month improvement thresholds for sleep quality and pain after reverse total shoulder arthroplasty.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sleep disturbance is a common patient-reported problem in patients undergoing reverse total shoulder arthroplasty (rTSA). However, clinically interpretable improvement thresholds for sleep quality after rTSA remain unclear. This study aimed to derive exploratory anchor-based 6-month improvement thresholds for sleep quality, assessed using the Pittsburgh Sleep Quality Index (PSQI), and pain, assessed using the visual analog scale (VAS), after rTSA. Methods: Sixty-one patients undergoing primary rTSA with complete pre-operative and 6-month post-operative PSQI, VAS, and global rating of change (GRC) data were retrospectively analyzed. Exploratory receiver-operating characteristic (ROC) curve analyses were performed using the GRC anchor, and Youden-derived thresholds were calculated. Anchor validity was assessed using Spearman correlation analysis between ordinal GRC responses and changes in PSQI and VAS. Results: rTSA was associated with significant 6-month improvements in both PSQI and VAS scores (both Conclusion: rTSA was associated with substantial 6-month improvements in sleep quality and pain. In this small retrospective cohort, exploratory anchor-based ROC analyses generated preliminary improvement thresholds of approximately 7 points for PSQI and 4 points for VAS pain. However, the weak PSQI anchor correlation, severe imbalance in anchor-defined groups, and modest ROC discrimination indicate that these estimates should be considered hypothesis-generating rather than definitive Minimal Clinically Important Difference values.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.